Back to News

Mahdi Loutfi wins the best presentation prize at the RRCancer Symposium

Mahdi Loutfi won the best presentation prize at the 13th RRCancer & Marathon of Hope Québec Symposium, held from September 30 to October 2, 2026 at the CHUM in Montréal, for his oral presentation on MEDiml.

For more details, see the event page.

Abstract

Purpose: Clinical translation of radiomics is hindered by the high-dimensional feature sets and lack of accessible tools for clinicians. MEDiml, an open-source platform designed to help democratize the development of radiomics models by identifying the simplest predictive features through both code-based and graphical interface.

Methods: MEDiml was evaluated using 89,714 features from five oncological datasets (n=2,104). Tasks included histology subtype prediction for non-small cell lung cancer (NSCLC, MRI); renal cell carcinoma (RCC, MRI); and RCC (contrast-enhanced-CT); IDH1 mutation prediction for low-grade glioma (LGG, MRI); and grade prediction for meningioma (MRI). For modeling, features are categorized by complexity (morphological, intensity, texture, linear/nonlinear filters) for XGBoost training. The pipeline cleans invariants and filters collinearity, retaining only features highly correlated with clinical endpoints.

Results: We released the MEDiml software with detailed documentation (mediml.app). Evaluation demonstrated that maximum predictive performance does not always require high-complexity features. Optimal levels were: morphological for LGG-IDH1 and Meningioma-grading; intensity in NSCLC and RCC -CECT; and texture for RCC-MRI. In the RCC-CECT cohort, optimizing the re-segmentation range, a parameter for excluding non-target voxels affecting intensity features, improved performance from an AUC of 0.82 to 0.86.

Conclusion: MEDiml successfully identifies the "optimal complexity level" for specific clinical outcomes, demonstrating that simpler models can often match or exceed the performance of high-dimensional sets. By providing an interactive, user-friendly interface and a strategy for feature minimization, MEDiml lowers the barrier to entry for clinicians, providing a scalable pathway for the clinical integration of radiomic biomarkers.

Event details

Date
Type
Best presentation prize
Venue
CHUM, Amphithéâtre Pierre-Péladeau, Montréal

Researchers